Status:
COMPLETED
CNAP in Heart Surgery
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
CNSystems Medizintechnik AG
Conditions:
Transfemoral Implantation of Aortic Valves
Eligibility:
All Genders
18+ years
Brief Summary
The role of continuous non-invasive arterial pressure (CNAP) in high risk patients with pronounced variation of arterial pressure will be assessed under analgosedation. Therefore, patients will be an...
Eligibility Criteria
Inclusion
- Patients admitted for elective transfemoral implantation of the aortic valve in analgosedation will be included.
- The patients' primary diagnosis was severe aortic stenosis, that was defined as a valve area of \<1cm² or a mean pressure gradient \>50mmHg.
Exclusion
- an advanced dysfunction of peripheral perfusion (i.e. pronounced arterial peripheral artery occlusive disease or Raynaud's syndrome)
- arterio-venous shunts for haemodialysis, and vascular surgery of the upper extremities
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01420484
Start Date
January 1 2010
End Date
December 1 2013
Last Update
December 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Clinic, University of heidelberg
Heidelberg, Germany, D-69120